ITRM20070668A1 - Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson - Google Patents

Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson

Info

Publication number
ITRM20070668A1
ITRM20070668A1 IT000668A ITRM20070668A ITRM20070668A1 IT RM20070668 A1 ITRM20070668 A1 IT RM20070668A1 IT 000668 A IT000668 A IT 000668A IT RM20070668 A ITRM20070668 A IT RM20070668A IT RM20070668 A1 ITRM20070668 A1 IT RM20070668A1
Authority
IT
Italy
Prior art keywords
levodopa
isothiocyanate
parkinson
association
disease
Prior art date
Application number
IT000668A
Other languages
English (en)
Inventor
Forti Giorgio Cantelli
Patrizia Hrelia
Fabiana Morroni
Andrea Tarozzi
Original Assignee
Alma Mater Studiorum Uni Di Bologna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alma Mater Studiorum Uni Di Bologna filed Critical Alma Mater Studiorum Uni Di Bologna
Priority to IT000668A priority Critical patent/ITRM20070668A1/it
Priority to PCT/IB2008/055377 priority patent/WO2009083871A1/en
Priority to US12/808,830 priority patent/US20100260737A1/en
Priority to CA2709524A priority patent/CA2709524A1/en
Priority to EP08867955A priority patent/EP2229166A1/en
Publication of ITRM20070668A1 publication Critical patent/ITRM20070668A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT000668A 2007-12-20 2007-12-20 Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson ITRM20070668A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000668A ITRM20070668A1 (it) 2007-12-20 2007-12-20 Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson
PCT/IB2008/055377 WO2009083871A1 (en) 2007-12-20 2008-12-17 Combination between an isothiocyanate and levodopa for parkinson's disease treatment
US12/808,830 US20100260737A1 (en) 2007-12-20 2008-12-17 Combination between an isothiocyanate and levodopa for parkinson's disease treatment
CA2709524A CA2709524A1 (en) 2007-12-20 2008-12-17 Combination between an isothiocyanate and levodopa for parkinson's disease treatment
EP08867955A EP2229166A1 (en) 2007-12-20 2008-12-17 Combination between an isothiocyanate and levodopa for parkinson's disease treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000668A ITRM20070668A1 (it) 2007-12-20 2007-12-20 Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson

Publications (1)

Publication Number Publication Date
ITRM20070668A1 true ITRM20070668A1 (it) 2009-06-21

Family

ID=40315847

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000668A ITRM20070668A1 (it) 2007-12-20 2007-12-20 Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson

Country Status (5)

Country Link
US (1) US20100260737A1 (it)
EP (1) EP2229166A1 (it)
CA (1) CA2709524A1 (it)
IT (1) ITRM20070668A1 (it)
WO (1) WO2009083871A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121774A1 (it) * 2012-10-19 2014-04-20 Placido Bramanti Uso di un fitochimico bioattivato come agente neuroprotettivo per la prevenzione ed il trattamento di patologie correlate al sistema nervoso
US10973815B2 (en) 2016-03-31 2021-04-13 Versi Group, Llc Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease

Also Published As

Publication number Publication date
US20100260737A1 (en) 2010-10-14
WO2009083871A1 (en) 2009-07-09
EP2229166A1 (en) 2010-09-22
CA2709524A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
ES2975234T3 (es) Dihidropteridinonas para el tratamiento de enfermedades cancerosas
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
ZA200909191B (en) Catecholamine derivatives useful for the treatment of parkinson's disease
IL191245A0 (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
EP1965827A4 (en) TREATMENT OF CONDITIONS RELATED TO DEMYELINATION
ZA200706868B (en) 4-Oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
DK1863899T3 (da) Hudbehandlingspræparater
CR10245A (es) "nuevas combinaciones terapéuticas para el tratamiento de la depresión"
AP2936A (en) Long term treatment of HIV-infection with TMC278
ITRM20050446A1 (it) Uso di stilbeni idrossilati e glucosidati per la prevenzione ed il trattamento di patologie oculari.
PT1945243E (pt) Utilização da calcitonina para o tratamento da ar
ITRM20070668A1 (it) Associazione tra un isotiocianato e levodopa per il trattamento della malattia di parkinson
IL186286A0 (en) Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
ITFI20050170A1 (it) Procedimento per la fabbricazione di dispositivi ortodontici e dispositivo ortodontico
ITPD20050026A1 (it) Attrezzatura per la produzione di ravioli e simili
ITMI20050891A1 (it) Formulazioni per il trattamento di psoriasi
ITRE20070127A1 (it) "dispositivo e metodo per il controllo delle attivita' fisiche di un individuo"
ITBO20050127A1 (it) Dispositivo per la deformazione di porzioni inferiori di pantaloni o simili
ITRM20060592A1 (it) Dispositivo impiantabile per il trattamento della patologia idrocefalica
ITMI20040726A1 (it) Procedimento per la preparazione di melatonina
UA17283S (uk) Конструкція для розміщення інформації («хаус-лайт» овел)
BRPI0716580A2 (pt) Tratamento de distúrbios fibrosantes
UA12915S (uk) Однострій українського козацтва